Anxiolytic compounds
US9573945B2 · kind B2 · utility
3Cited by
52References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2014 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Nov 5, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to chemical compounds of general formula (I)which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.